Cargando…
The Role of Intestinal Dysbacteriosis Induced Arachidonic Acid Metabolism Disorder in Inflammaging in Atherosclerosis
BACKGROUND: Aging induced chronic systemic inflammatory response is an important risk factor for atherosclerosis (AS) development; however, the detailed mechanism is yet to be elucidated. OBJECTIVE: To explore the underlying mechanism of how aging aggravates AS advancement. METHODS: A young (five-we...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8012722/ https://www.ncbi.nlm.nih.gov/pubmed/33816331 http://dx.doi.org/10.3389/fcimb.2021.618265 |
_version_ | 1783673425673322496 |
---|---|
author | Sun, Yingxin Wu, Danbin Zeng, Wenyun Chen, Yefei Guo, Maojuan Lu, Bin Li, Huhu Sun, Chun Yang, Lin Jiang, Xijuan Gao, Qing |
author_facet | Sun, Yingxin Wu, Danbin Zeng, Wenyun Chen, Yefei Guo, Maojuan Lu, Bin Li, Huhu Sun, Chun Yang, Lin Jiang, Xijuan Gao, Qing |
author_sort | Sun, Yingxin |
collection | PubMed |
description | BACKGROUND: Aging induced chronic systemic inflammatory response is an important risk factor for atherosclerosis (AS) development; however, the detailed mechanism is yet to be elucidated. OBJECTIVE: To explore the underlying mechanism of how aging aggravates AS advancement. METHODS: A young (five-week-old, YM) and aged group (32-week-old, OM) male apoE(-/-) mice with a high fat diet were used as models, and age-matched male wild-type C57BL/6J (WT) mice were used as controls. AS lesion size, serum lipid profile, cytokines, and gut microbiota-derived LPS were analyzed after 32 weeks of diet intervention. A correlation analysis between the 16S rRNA sequencing of the feces and serum metabolomics profiles was applied to examine the effect of their interactions on AS. RESULTS: ApoE(-/-) mice developed severe atherosclerosis and inflammation in the aorta compared to the WT groups, and aged apoE(-/-) mice suffered from a more severe AS lesion than their younger counterparts and had low-grade systemic inflammation. Furthermore, increased levels of serum LPS, decreased levels of SCFAs production, as well as dysfunction of the ileal mucosal barrier were detected in aged mice compared with their younger counterparts. There were significant differences in the intestinal flora composition among the four groups, and harmful bacteria such as Lachnospiraceae_FCS020, Ruminococcaceae_UCG-009, Acetatifactor, Lachnoclostridium and Lactobacillus_gasseri were significantly increased in the aged apoE(-/-) mice compared with the other groups. Concurrently, metabolomics profiling revealed that components involved in the arachidonic acid (AA) metabolic pathway such as 20-HETE, PGF2α, arachidonic acid, and LTB4 were significantly higher in the aged AS group than in the other groups. This suggested that metabolic abnormalities and disorders of intestinal flora occurred in AS mice. CONCLUSIONS: Aging not only altered the gut microbiome community but also substantially disturbed metabolic conditions. Our results confirm that AA metabolism is associated with the imbalance of the intestinal flora in the AS lesions of aged mice. These findings may offer new insights regarding the role of gut flora disorders and its consequent metabolite changed in inflammaging during AS development. |
format | Online Article Text |
id | pubmed-8012722 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-80127222021-04-02 The Role of Intestinal Dysbacteriosis Induced Arachidonic Acid Metabolism Disorder in Inflammaging in Atherosclerosis Sun, Yingxin Wu, Danbin Zeng, Wenyun Chen, Yefei Guo, Maojuan Lu, Bin Li, Huhu Sun, Chun Yang, Lin Jiang, Xijuan Gao, Qing Front Cell Infect Microbiol Cellular and Infection Microbiology BACKGROUND: Aging induced chronic systemic inflammatory response is an important risk factor for atherosclerosis (AS) development; however, the detailed mechanism is yet to be elucidated. OBJECTIVE: To explore the underlying mechanism of how aging aggravates AS advancement. METHODS: A young (five-week-old, YM) and aged group (32-week-old, OM) male apoE(-/-) mice with a high fat diet were used as models, and age-matched male wild-type C57BL/6J (WT) mice were used as controls. AS lesion size, serum lipid profile, cytokines, and gut microbiota-derived LPS were analyzed after 32 weeks of diet intervention. A correlation analysis between the 16S rRNA sequencing of the feces and serum metabolomics profiles was applied to examine the effect of their interactions on AS. RESULTS: ApoE(-/-) mice developed severe atherosclerosis and inflammation in the aorta compared to the WT groups, and aged apoE(-/-) mice suffered from a more severe AS lesion than their younger counterparts and had low-grade systemic inflammation. Furthermore, increased levels of serum LPS, decreased levels of SCFAs production, as well as dysfunction of the ileal mucosal barrier were detected in aged mice compared with their younger counterparts. There were significant differences in the intestinal flora composition among the four groups, and harmful bacteria such as Lachnospiraceae_FCS020, Ruminococcaceae_UCG-009, Acetatifactor, Lachnoclostridium and Lactobacillus_gasseri were significantly increased in the aged apoE(-/-) mice compared with the other groups. Concurrently, metabolomics profiling revealed that components involved in the arachidonic acid (AA) metabolic pathway such as 20-HETE, PGF2α, arachidonic acid, and LTB4 were significantly higher in the aged AS group than in the other groups. This suggested that metabolic abnormalities and disorders of intestinal flora occurred in AS mice. CONCLUSIONS: Aging not only altered the gut microbiome community but also substantially disturbed metabolic conditions. Our results confirm that AA metabolism is associated with the imbalance of the intestinal flora in the AS lesions of aged mice. These findings may offer new insights regarding the role of gut flora disorders and its consequent metabolite changed in inflammaging during AS development. Frontiers Media S.A. 2021-03-18 /pmc/articles/PMC8012722/ /pubmed/33816331 http://dx.doi.org/10.3389/fcimb.2021.618265 Text en Copyright © 2021 Sun, Wu, Zeng, Chen, Guo, Lu, Li, Sun, Yang, Jiang and Gao http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cellular and Infection Microbiology Sun, Yingxin Wu, Danbin Zeng, Wenyun Chen, Yefei Guo, Maojuan Lu, Bin Li, Huhu Sun, Chun Yang, Lin Jiang, Xijuan Gao, Qing The Role of Intestinal Dysbacteriosis Induced Arachidonic Acid Metabolism Disorder in Inflammaging in Atherosclerosis |
title | The Role of Intestinal Dysbacteriosis Induced Arachidonic Acid Metabolism Disorder in Inflammaging in Atherosclerosis |
title_full | The Role of Intestinal Dysbacteriosis Induced Arachidonic Acid Metabolism Disorder in Inflammaging in Atherosclerosis |
title_fullStr | The Role of Intestinal Dysbacteriosis Induced Arachidonic Acid Metabolism Disorder in Inflammaging in Atherosclerosis |
title_full_unstemmed | The Role of Intestinal Dysbacteriosis Induced Arachidonic Acid Metabolism Disorder in Inflammaging in Atherosclerosis |
title_short | The Role of Intestinal Dysbacteriosis Induced Arachidonic Acid Metabolism Disorder in Inflammaging in Atherosclerosis |
title_sort | role of intestinal dysbacteriosis induced arachidonic acid metabolism disorder in inflammaging in atherosclerosis |
topic | Cellular and Infection Microbiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8012722/ https://www.ncbi.nlm.nih.gov/pubmed/33816331 http://dx.doi.org/10.3389/fcimb.2021.618265 |
work_keys_str_mv | AT sunyingxin theroleofintestinaldysbacteriosisinducedarachidonicacidmetabolismdisorderininflammaginginatherosclerosis AT wudanbin theroleofintestinaldysbacteriosisinducedarachidonicacidmetabolismdisorderininflammaginginatherosclerosis AT zengwenyun theroleofintestinaldysbacteriosisinducedarachidonicacidmetabolismdisorderininflammaginginatherosclerosis AT chenyefei theroleofintestinaldysbacteriosisinducedarachidonicacidmetabolismdisorderininflammaginginatherosclerosis AT guomaojuan theroleofintestinaldysbacteriosisinducedarachidonicacidmetabolismdisorderininflammaginginatherosclerosis AT lubin theroleofintestinaldysbacteriosisinducedarachidonicacidmetabolismdisorderininflammaginginatherosclerosis AT lihuhu theroleofintestinaldysbacteriosisinducedarachidonicacidmetabolismdisorderininflammaginginatherosclerosis AT sunchun theroleofintestinaldysbacteriosisinducedarachidonicacidmetabolismdisorderininflammaginginatherosclerosis AT yanglin theroleofintestinaldysbacteriosisinducedarachidonicacidmetabolismdisorderininflammaginginatherosclerosis AT jiangxijuan theroleofintestinaldysbacteriosisinducedarachidonicacidmetabolismdisorderininflammaginginatherosclerosis AT gaoqing theroleofintestinaldysbacteriosisinducedarachidonicacidmetabolismdisorderininflammaginginatherosclerosis AT sunyingxin roleofintestinaldysbacteriosisinducedarachidonicacidmetabolismdisorderininflammaginginatherosclerosis AT wudanbin roleofintestinaldysbacteriosisinducedarachidonicacidmetabolismdisorderininflammaginginatherosclerosis AT zengwenyun roleofintestinaldysbacteriosisinducedarachidonicacidmetabolismdisorderininflammaginginatherosclerosis AT chenyefei roleofintestinaldysbacteriosisinducedarachidonicacidmetabolismdisorderininflammaginginatherosclerosis AT guomaojuan roleofintestinaldysbacteriosisinducedarachidonicacidmetabolismdisorderininflammaginginatherosclerosis AT lubin roleofintestinaldysbacteriosisinducedarachidonicacidmetabolismdisorderininflammaginginatherosclerosis AT lihuhu roleofintestinaldysbacteriosisinducedarachidonicacidmetabolismdisorderininflammaginginatherosclerosis AT sunchun roleofintestinaldysbacteriosisinducedarachidonicacidmetabolismdisorderininflammaginginatherosclerosis AT yanglin roleofintestinaldysbacteriosisinducedarachidonicacidmetabolismdisorderininflammaginginatherosclerosis AT jiangxijuan roleofintestinaldysbacteriosisinducedarachidonicacidmetabolismdisorderininflammaginginatherosclerosis AT gaoqing roleofintestinaldysbacteriosisinducedarachidonicacidmetabolismdisorderininflammaginginatherosclerosis |